(Q67490035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:786673%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:786673%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

author name string

M. Motolese

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A786673

28 July 2022

G. Muiesan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A786673

28 July 2022

A. Colombi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A786673

28 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=786673

28 July 2022

publication date

1 January 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:786673%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

14 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:786673%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:786673%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:786673%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

21-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:786673%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00616411

14 September 2019

exact match

0 references

cites work

Propranolol as an antihypertensive agent

1 reference

12 December 2020

Effects of 1-4-dihydrazinophthalazine on arterial pressure and heart rate, before and after administration of beta-blocking drugs

1 reference

12 December 2020

A long-term study of the antihypertensive effect of alprenolol

1 reference

12 December 2020

Hypertension therapy with propanolol and hydralazine

1 reference

12 December 2020

Inhibition of the carotid sinus reflex by the chronic administration of propranolol

1 reference

12 December 2020

The use of propranolol in the treatment of hypertension

1 reference

12 December 2020

Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness

1 reference

12 December 2020

Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.

1 reference

12 December 2020

Beta-adrenergic blocking therapy in hypertension: selection of patients

1 reference

12 December 2020

β-Adrenergic Receptors in the Central Nervous System of the Cat concerned with Control of Arterial Blood Pressure and Heart Rate

1 reference

12 December 2020

Relation of hydralazine plasma concentration to dosage and hypotensive action

1 reference

12 December 2020

Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine

1 reference

12 December 2020

Effect of propranolol on elevated arterial blood pressure

1 reference

12 December 2020

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

1 reference

12 December 2020

Ineffectiveness of propranolol in hypertensive Jamaicans

1 reference

12 December 2020

Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.

1 reference

12 December 2020

Treatment of Hypertension with Propranolol

1 reference

12 December 2020

Haemodynamic studies in hypertensive patients treated by oral propranolol

1 reference

12 December 2020

Controlled trial of oxprenolol and practolol in hypertension.

1 reference

12 December 2020

Antihypertensive therapy with alprenolol, a beta-adrenergic receptor antagonist

1 reference

12 December 2020

Propranolol in the South African non-white hypertensive patient

1 reference

12 December 2020

Effect of propranolol in mild hypertension

1 reference

12 December 2020

The effect of selective cardiac adrenergic beta-blockade on the hypotensive effect of hydrallazine

1 reference

12 December 2020

Evaluation of the hypotensive effect of beta-adrenergic blockade in hypertension

1 reference

12 December 2020

Effect of alprenolol and alprenolol in combination with saluretics in hypertension

1 reference

12 December 2020

Treatment of hypertension with high doses of oxprenolol alone or in combination with the vasodilator dihydralazine

1 reference

12 December 2020

Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators

1 reference

12 December 2020

Comparison between alprenolol and chlorthalidone as antihypertensive agents

1 reference

12 December 2020

The use of prindolol (Visken) in the treatment of hypertension

1 reference

12 December 2020

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

1 reference

12 December 2020

Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients

1 reference

12 December 2020

Central cardiovascular effects of intracerebroventricular propranolol

1 reference

12 December 2020

Effect of aptin, a beta-adrenergic blocking agent, in arterial hypertension

1 reference

12 December 2020

Why Do Thiazide Diuretics Lower Blood Pressure in Essential Hypertension?

1 reference

12 December 2020

Propranolol in hypertension

1 reference

12 December 2020

Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.

1 reference

12 December 2020

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

1 reference

12 December 2020

Controlled trial of propranolol in hypertension

1 reference

12 December 2020

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

1 reference

12 December 2020

Oxprenolol: Long-term effects in arterial hypertension

1 reference

12 December 2020

Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity

1 reference

12 December 2020

Changes induced by acute and prolonged administration of propranolol in systemic hemodynamics in hypertensive patients

1 reference

12 December 2020

Central hypotensive effect of propranolol in the rabbit

1 reference

12 December 2020

Treatment of hypertension with propranolol and hydralazine

1 reference

12 December 2020

Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease

1 reference

12 December 2020

Propranolol in hypertension: a study of long-term therapy, 1964-1970

1 reference

12 December 2020

Combined dihydralazine and propranolol in the treatment of hypertension

1 reference

12 December 2020

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

1 reference

12 December 2020

Treatment of hypertension with alprenolol and hydralazine

1 reference

12 December 2020

Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.

1 reference

12 December 2020

USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

1 reference

12 December 2020

The paradox of beta-adrenergic blockade in hypertension

1 reference

12 December 2020

Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.

1 reference

12 December 2020

Propranolol in hypertension

1 reference

12 December 2020

A study of the mechanism of the hemodynamic effects of hydralazine in man

1 reference

12 December 2020

Experiences with beta-adrenergic blockade drugs in hypertension.

1 reference

12 December 2020

Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man

1 reference

12 December 2020

Plasma volume changes with long-term beta-adrenergic blockade

1 reference

12 December 2020

Some haemodynamic effects of trasicor (Ciba 39,089-Ba)

1 reference

12 December 2020

Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment

1 reference

12 December 2020

Hypotensive action of propranolol

1 reference

12 December 2020

Propranolol in hypertension

1 reference

12 December 2020

Propranolol in hypertension. Report on 158 patients treated up to one year

1 reference

12 December 2020

Propranolol therapy in essential hypertension

1 reference

12 December 2020

The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study

1 reference

12 December 2020

The Antidiuretic Action of Diazoxide

1 reference

12 December 2020

Haemodynamic effects of Trasicor, a new beta-adrenergic blocking agent, in hypertensive patients

1 reference

12 December 2020

Anti-hypertensive effectiveness of long-term oral administration of propranolol

1 reference

12 December 2020

Pharmacological aspects of oxprenolol

1 reference

12 December 2020

Propranolol and polythiazide in treatment of hypertension

1 reference

12 December 2020

Haemodynamic effects of oxprenolol in hypertensive patients.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00616411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:786673%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference